{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:50:27Z","timestamp":1791341427935,"version":"4.3.1"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:00:00Z","timestamp":1655424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Current vaccination strategies against influenza focus on generating an antibody response against the viral haemagglutination surface protein, however there is increasing interest in neuraminidase (NA) as a target for vaccine development. A critical tool for development of vaccines that target NA or include an NA component is available validated serology assays for quantifying anti-NA antibodies. Additionally serology assays have a critical role in defining correlates of protection in vaccine development and licensure. Standardisation of these assays is important for consistent and accurate results. In this study we first validated a harmonized enzyme-linked lectin assay (ELLA)- Neuraminidase Inhibition (NI) SOP for N1 influenza antigen and demonstrated the assay was precise, linear, specific and robust within classical acceptance criteria for neutralization assays for vaccine testing. Secondly we tested this SOP with NA from influenza B viruses and showed the assay performed consistently with both influenza A and B antigens. Third, we demonstrated that recombinant NA (rNA) could be used as a source of antigen in ELLA-NI. In addition to validating a harmonized SOP we finally demonstrated a clear improvement in inter-laboratory agreement across several studies by using a calibrator. Importantly we showed that the use of a calibrator significantly improved agreement when using different sources of antigen in ELLA-NI, namely reverse genetics viruses and recombinant NA. We provide a freely available and detailed harmonized SOP for ELLA-NI. Our results add to the growing body of evidence in support of developing biological standards for influenza serology.<\/jats:p>","DOI":"10.3389\/fimmu.2022.909297","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T11:12:12Z","timestamp":1655464332000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Validation of a Harmonized Enzyme-Linked-Lectin-Assay (ELLA-NI) Based Neuraminidase Inhibition Assay Standard Operating Procedure (SOP) for Quantification of N1 Influenza Antibodies and the Use of a Calibrator to Improve the Reproducibility of the ELLA-NI With Reverse Genetics Viral and Recombinant Neuraminidase Antigens: A FLUCOP Collaborative Study"],"prefix":"10.3389","volume":"13","author":[{"given":"Marie-Clotilde","family":"Bernard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Waldock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Commandeur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Strau\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia Maria","family":"Trombetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Marchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"van de Witte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"van Amsterdam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sammy","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Hoschler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Lugovtsev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry P.","family":"Weir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Montomoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca J.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Othmar G.","family":"Engelhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Friel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Ollinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Germain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Sediri-Sch\u00f6n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R110.129809","article-title":"Influenza Hemagglutinin and Neuraminidase Membrane Glycoproteins","volume":"285","author":"Gamblin","year":"2010","journal-title":"J Biol Chem"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2016.07.007","article-title":"Functional Balance Between Neuraminidase and Haemagglutinin in Influenza Viruses","volume":"22","author":"Gaymard","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.1713","article-title":"Contribution of Antibody Production Against Neuraminidase to the Protection Afforded by Influenza Vaccines","volume":"22","author":"Marcelin","year":"2012","journal-title":"Rev Med Virol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2019.00344","article-title":"The Quest for a Truly Universal Influenza Vaccine","volume":"9","author":"Jang","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0143-6","article-title":"The Human Antibody Response to Influenza A Virus Infection and Vaccination","volume":"19","author":"Krammer","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/v6062465","article-title":"In the Shadow of Hemagglutinin: A Growing Interest in Influenza Viral Neuraminidase and Its Role as a Vaccine Antigen","volume":"6","author":"Wohlbold","year":"2014","journal-title":"Viruses"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv195","article-title":"Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection","volume":"212","author":"Monto","year":"2015","journal-title":"J\u00a0Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00417-16","article-title":"Evaluation of Antihemagglutinin and Antineuraminidase Antibodies as Correlates of Protection in an Influenza A\/H1N1 Virus Healthy Human Challenge Model","volume":"7","author":"Memoli","year":"2016","journal-title":"mBio"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-016-2907-7","article-title":"Influenza Virus Neuraminidase (NA): A Target for Antivirals and Vaccines","volume":"161","author":"Jagadesh","year":"2016","journal-title":"Arch Virol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2013.09.018","article-title":"Universal Anti-Neuraminidase Antibody Inhibiting All Influenza A Subtypes","volume":"100","author":"Doyle","year":"2013","journal-title":"Antiviral Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2013.10.041","article-title":"A Monoclonal Antibody Targeting a Highly Conserved Epitope in Influenza B Neuraminidase Provides Protection Against Drug Resistant Strains","volume":"441","author":"Doyle","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2016.1164046","article-title":"Influenza Immunology Evaluation and Correlates of Protection: A Focus on Vaccines","volume":"15","author":"Trombetta","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"B13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41541-019-0099-3","article-title":"A Neuraminidase Potency Assay for Quantitative Assessment of Neuraminidase in Influenza Vaccines","volume":"4","author":"Byrne-Nash","year":"2019","journal-title":"NPJ Vaccines"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.02.084","article-title":"WHO Meeting on the Role of Neuraminidase in Inducing Protective Immunity Against Influenza Infection, Vilamoura, Portugal, September 14, 2008","volume":"27","author":"Bright","year":"2009","journal-title":"Vaccine"},{"key":"B15","volume-title":"Guideline on Influenza Vaccines","year":"2016"},{"key":"B16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0022-1759(90)90255-T","article-title":"Measurement of Anti-Influenza Neuraminidase Antibody Using a Peroxidase-Linked Lectin and Microtitre Plates Coated With Natural Substrates","volume":"135","author":"Lambr\u00e9","year":"1990","journal-title":"J Immunol Methods"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines2040707","article-title":"Overview of Serological Techniques for Influenza Vaccine Evaluation: Past, Present and Future","volume":"2","author":"Trombetta","year":"2014","journal-title":"Vaccines (Basel)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3791\/54573","article-title":"Measuring Influenza Neuraminidase Inhibition Antibody Titers by Enzyme-Linked Lectin Assay","volume":"115","author":"Gao","year":"2016","journal-title":"J Visualized Experiments"},{"key":"B19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jviromet.2014.09.003","article-title":"An Optimized Enzyme-Linked Lectin Assay to Measure Influenza A Virus Neuraminidase Inhibition Antibody Titers in Human Sera","volume":"210","author":"Couzens","year":"2014","journal-title":"J Virol Methods"},{"key":"B20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jviromet.2015.02.014","article-title":"Optimization of an Enzyme-Linked Lectin Assay Suitable for Rapid Antigenic Characterization of the Neuraminidase of Human Influenza A(H3N2) Viruses","volume":"217","author":"Westgeest","year":"2015","journal-title":"J Virol Methods"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.12.022","article-title":"Comparability of Neuraminidase Inhibition Antibody Titers Measured by Enzyme-Linked Lectin Assay (ELLA) for the Analysis of Influenza Vaccine Immunogenicity","volume":"34","author":"Eichelberger","year":"2016","journal-title":"Vaccine"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz017","article-title":"Neuraminidase, the Forgotten Surface Antigen, Emerges as an Influenza Vaccine Target for Broadened Protection","volume":"219","author":"Eichelberger","year":"2019","journal-title":"J Infect Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/infdis\/jir711","article-title":"A Vero Cell-Derived Whole-Virus H5N1 Vaccine Effectively Induces Neuraminidase-Inhibiting Antibodies","volume":"205","author":"Fritz","year":"2012","journal-title":"J Infect Dis"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2016.10.024","article-title":"Influenza A Virus Hemagglutinin Specific Antibodies Interfere With Virion Neuraminidase Activity via Two Distinct Mechanisms","volume":"500","author":"Kosik","year":"2017","journal-title":"Virology"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.10.065","article-title":"Randomized Comparative Study of the Serum Antihemagglutinin and Antineuraminidase Antibody Responses to Six Licensed Trivalent Influenza Vaccines","volume":"31","author":"Couch","year":"2012","journal-title":"Vaccine"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12669","article-title":"Use of Lentiviral Pseudotypes as an Alternative to Reassortant or Triton X-100-Treated Wild-Type Influenza Viruses in the Neuraminidase Inhibition Enzyme-Linked Lectin Assay","volume":"13","author":"Biuso","year":"2019","journal-title":"Influenza Other Respir Viruses"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.12.041","article-title":"A High Dosage Influenza Vaccine Induced Significantly More Neuraminidase Antibody Than Standard Vaccine Among Elderly Subjects","volume":"28","author":"Cate","year":"2010","journal-title":"Vaccine"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02281-16","article-title":"Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin","volume":"8","author":"Rajendran","year":"2017","journal-title":"mBio"},{"key":"B29","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/antib9020020","article-title":"Study of Neuraminidase-Inhibiting Antibodies in Clinical Trials of Live Influenza Vaccines","volume":"9","author":"Desheva","year":"2020","journal-title":"Antibodies (Basel)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.100133697","article-title":"A DNA Transfection System for Generation of Influenza A Virus From Eight Plasmids","volume":"97","author":"Hoffmann","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1023\/A:1026451721686","article-title":"Confidence Interval Criteria for Assessment of Dose Proportionality","volume":"17","author":"Smith","year":"2000","journal-title":"Pharm Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01182-19","article-title":"Broadly Inhibiting Antineuraminidase Monoclonal Antibodies Induced by Trivalent Influenza Vaccine and H7N9 Infection in Humans","volume":"94","author":"Rijal","year":"2020","journal-title":"J Virol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-0346-8_24","article-title":"Detection and Titration of Influenza A Virus Neuraminidase Inhibiting (NAI) Antibodies Using an Enzyme-Linked Lectin Assay (ELLA)","volume":"2123","author":"Kaplan","year":"2020","journal-title":"Methods Mol Biol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1113801108","article-title":"Discordant Antigenic Drift of Neuraminidase and Hemagglutinin in H1N1 and H3N2 Influenza Viruses","volume":"108","author":"Sandbulte","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2017.0141","article-title":"Influenza Virus: Dealing With a Drifting and Shifting Pathogen","volume":"31","author":"Kim","year":"2018","journal-title":"Viral Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(94)90056-6","article-title":"Comparison of Influenza Serological Techniques by International Collaborative Study","volume":"12","author":"Wood","year":"1994","journal-title":"Vaccine"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3201\/eid1508.081754","article-title":"Reproducibility of Serologic Assays for Influenza Virus A (H5n1)","volume":"15","author":"Stephenson","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-2659.2012.0370a.x","article-title":"Influenza Serological Studies to Inform Public Health Action: Best Practices to Optimise Timing, Quality and Reporting","volume":"7","author":"Laurie","year":"2012","journal-title":"Influenza Other Respir Viruses"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.02.077","article-title":"Enhancing the Reproducibility of Serological Methods Used to Evaluate Immunogenicity of Pandemic H1N1 Influenza Vaccines\u2014An Effective EU Regulatory Approach","volume":"30","author":"Wagner","year":"2012","journal-title":"Vaccine"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.11.019","article-title":"Reproducibility of Serology Assays for Pandemic Influenza H1N1: Collaborative Study to Evaluate a Candidate WHO International Standard","volume":"30","author":"Wood","year":"2012","journal-title":"Vaccine"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-2-3-385","article-title":"Serological Relationships Between the Neuraminidases in Influenza Viruses","volume":"2","author":"Paniker","year":"1968","journal-title":"J Gen Virol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135474","article-title":"Expression and Characterization of Recombinant, Tetrameric and Enzymatically Active Influenza Neuraminidase for the Setup of an Enzyme-Linked Lectin-Based Assay","volume":"10","author":"Prevato","year":"2015","journal-title":"PLoS One"},{"key":"B43","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/0167-4838(91)90526-6","article-title":"Influenza Virus Sialidase: Effect of Calcium on Steady-State Kinetic Parameters","volume":"1077","author":"Chong","year":"1991","journal-title":"Biochim Biophys Acta"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/prot.22761","article-title":"Impact of Calcium on N1 Influenza Neuraminidase Dynamics and Binding Free Energy","volume":"78","author":"Lawrenz","year":"2010","journal-title":"Proteins"},{"key":"B45","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41541-021-00310-x","article-title":"The Effect of Calcium and Magnesium on Activity, Immunogenicity, and Efficacy of a Recombinant N1\/N2 Neuraminidase Vaccine","volume":"6","author":"Giurgea","year":"2021","journal-title":"NPJ Vaccines"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-75-2-381","article-title":"Calcium is Needed for the Thermostability of Influenza B Virus Neuraminidase","volume":"75","author":"Burmeister","year":"1994","journal-title":"J Gen Virol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.909297\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T11:12:17Z","timestamp":1655464337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.909297\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,17]]},"references-count":46,"alternative-id":["10.3389\/fimmu.2022.909297"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.909297","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,17]]},"article-number":"909297"}}